In October 2024, the UK government announced funding had been agreed to support HPP1 as the UK's first large-scale low carbon hydrogen project at the heart of the HyNet Cluster.
A type of blood cells, called peripheral blood (PB) or bone marrow-derived endothelial progenitor cells (EPCs), contribute to the formation of blood vessels, and thus help in wound healing.
Crisil Ratings in a note issued said that the healthy order book position of the road EPC companies, is expected to improve further supported by new project awarding momentum.